Shares of the Fundrise Innovation Fund, listed under the symbol VCX, moved higher on Tuesday, gaining as much as 39% to reach $265 per share. Tuesday represented the fund's fourth day of trading since its market debut last week, and the session included several temporary trading halts as volatility spiked.
The market price is now more than 1,300% above the fund's most recently disclosed net asset value of $18.97 per share. Market participants bid up the constrained supply of freely tradable shares to a level exceeding 13 times that NAV figure.
The fund's disclosed portfolio includes stakes in several private companies that are viewed as potential initial public offering candidates. Holdings cited in regulatory filings include SpaceX and Anthropic PBC. The fund also reports positions in OpenAI Inc., Anduril Industries Inc., Databricks Inc. and Ramp Inc.
According to securities filings, Fundrise proposed converting to a publicly listed closed-end vehicle nearly five years after launching operations. The stated goals in those filings were to create potential value and to increase liquidity for investors, objectives the listing was intended to support.
Despite the open market trading, the majority of the fund's shares remain under lockup restrictions. For roughly 100,000 investors who held shares prior to the market debut, any VCX shares acquired before Feb. 20 are barred from sale for six months following the listing, the filings state. That constraint leaves only a limited float available to absorb the pronounced buying pressure since the fund began trading.
Context and market mechanics
The combination of a small free float and strong investor demand produced sharp price divergence from the fund's reported NAV. The multiple trading halts on Tuesday reflect exchange mechanisms designed to address extreme price swings in thinly traded or heavily bid securities. The lockup provisions and the limited availability of shares prior to expiration mean market pricing may continue to reflect supply-demand dislocations rather than changes in the underlying valuations reported in the fund's filings.
The fund's positions in high-profile private companies have likely contributed to investor interest, but the regulatory filings emphasize the fund's conversion objective and the existing shareholder constraints without providing forward guidance about liquidity beyond the terms of the lockup.